Lisdexamfetamine dimesylate 60 MG Oral Capsule — RxCUI 854846
RxNorm drug concept · Semantic clinical drug
RxCUI 854846
Semantic clinical drug · SCD
● Current RxNorm concept 136 FDA products
137 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI854846
Official nameLisdexamfetamine dimesylate 60 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped136
Package NDCs mapped137
Reported Medicaid activity (SDUD)3,901,442 prescriptions · 51 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Lisdexamfetamine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Lisdexamfetamine is used to treat two conditions: ADHD in adults and kids age 6 and older, and moderate to severe binge eating disorder in adults. It's not approved for weight loss...
- What exactly is lisdexamfetamine used for?
- The most common ones are decreased appetite, trouble sleeping, dry mouth, nausea, and weight loss. Some people also feel jittery or anxious, especially early on. Most of these tend...
- What are the most common side effects I should expect?
🕸️ Concept Web — How Lisdexamfetamine dimesylate 60 MG Oral Capsule Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Lisdexamfetamine dimesylate 60 MG Oral Capsule
RxCUI 854846 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Lisdexamfetamine
700810IN -
Lisdexamfetamine dimesylate
673579PIN
-
Lisdexamfetamine
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Vyvanse
711043BN
-
Vyvanse
-
Dose forms 13
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Lisdexamfetamine Oral Capsule
700812SCDF -
Lisdexamfetamine dimesylate Oral Capsule
2645468SCDFP -
Lisdexamfetamine Oral Product
1164687SCDG -
Lisdexamfetamine Pill
1164688SCDG -
Lisdexamfetamine dimesylate Oral Product
2663335SCDGP -
Lisdexamfetamine dimesylate Pill
2660535SCDGP -
Lisdexamfetamine Oral Capsule [Vyvanse]
705294SBDF -
Lisdexamfetamine dimesylate Oral Capsule [Vyvanse]
2655540SBDFP - +5 more in this family
-
Lisdexamfetamine Oral Capsule
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Lisdexamfetamine dimesylate 60 MG
854845SCDC -
Lisdexamfetamine dimesylate 60 MG Oral Capsule [Vyvanse]
854848SBD -
Lisdexamfetamine dimesylate 60 MG [Vyvanse]
854847SBDC
-
Lisdexamfetamine dimesylate 60 MG
Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Lisdexamfetamine dimesylate 60 MG
SCDC · 854845 -
Lisdexamfetamine Oral Capsule
SCDF · 700812 -
Lisdexamfetamine dimesylate Oral Capsule
SCDFP · 2645468 -
Lisdexamfetamine Oral Product
SCDG · 1164687 -
Lisdexamfetamine Pill
SCDG · 1164688 -
Lisdexamfetamine dimesylate Oral Product
SCDGP · 2663335 -
Lisdexamfetamine dimesylate Pill
SCDGP · 2660535
Brand-Name Concepts
-
Lisdexamfetamine dimesylate 60 MG Oral Capsule [Vyvanse]
SBD · 854848 -
Lisdexamfetamine dimesylate 60 MG [Vyvanse]
SBDC · 854847 -
Lisdexamfetamine Oral Capsule [Vyvanse]
SBDF · 705294 -
Lisdexamfetamine dimesylate Oral Capsule [Vyvanse]
SBDFP · 2655540 -
Vyvanse Oral Product
SBDG · 1187603 -
Vyvanse Pill
SBDG · 1187604 -
Vyvanse
BN · 711043
📦 FDA Products & Package NDCs
136 products · 137 package NDCs
137 package NDCs map to RxCUI 854846 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00054-0370-25 | 100 CAPSULE in 1 BOTTLE (0054-0370-25) | Lisdexamfetamine Dimesylate | Hikma Pharmaceuticals USA Inc. | 2023-08-25 |
| 00054-0371-25 | 100 CAPSULE in 1 BOTTLE (0054-0371-25) | Lisdexamfetamine Dimesylate | Hikma Pharmaceuticals USA Inc. | 2023-08-25 |
| 00054-0372-25 | 100 CAPSULE in 1 BOTTLE (0054-0372-25) | Lisdexamfetamine Dimesylate | Hikma Pharmaceuticals USA Inc. | 2023-08-25 |
| 00054-0373-25 | 100 CAPSULE in 1 BOTTLE (0054-0373-25) | Lisdexamfetamine Dimesylate | Hikma Pharmaceuticals USA Inc. | 2023-08-25 |
| 00054-0374-25 | 100 CAPSULE in 1 BOTTLE (0054-0374-25) | Lisdexamfetamine Dimesylate | Hikma Pharmaceuticals USA Inc. | 2023-08-25 |
| 00054-0375-25 | 100 CAPSULE in 1 BOTTLE (0054-0375-25) | Lisdexamfetamine Dimesylate | Hikma Pharmaceuticals USA Inc. | 2023-08-25 |
| 00054-0660-25 | 100 CAPSULE in 1 BOTTLE (0054-0660-25) | Lisdexamfetamine Dimesylate | Hikma Pharmaceuticals USA Inc. | 2024-01-17 |
| 00378-6854-77 | 90 CAPSULE in 1 BOTTLE, PLASTIC (0378-6854-77) | Lisdexamfetamine Dimesylate | Mylan Pharmaceuticals Inc. | 2023-08-25 |
| 00378-6855-77 | 90 CAPSULE in 1 BOTTLE, PLASTIC (0378-6855-77) | Lisdexamfetamine Dimesylate | Mylan Pharmaceuticals Inc. | 2023-08-25 |
| 00378-6856-77 | 90 CAPSULE in 1 BOTTLE, PLASTIC (0378-6856-77) | Lisdexamfetamine Dimesylate | Mylan Pharmaceuticals Inc. | 2023-08-25 |
| 00378-6857-77 | 90 CAPSULE in 1 BOTTLE, PLASTIC (0378-6857-77) | Lisdexamfetamine Dimesylate | Mylan Pharmaceuticals Inc. | 2023-08-25 |
| 00378-6858-77 | 90 CAPSULE in 1 BOTTLE, PLASTIC (0378-6858-77) | Lisdexamfetamine Dimesylate | Mylan Pharmaceuticals Inc. | 2023-08-25 |
| 00378-6859-77 | 90 CAPSULE in 1 BOTTLE, PLASTIC (0378-6859-77) | Lisdexamfetamine Dimesylate | Mylan Pharmaceuticals Inc. | 2023-08-25 |
| 00378-6860-77 | 90 CAPSULE in 1 BOTTLE, PLASTIC (0378-6860-77) | Lisdexamfetamine Dimesylate | Mylan Pharmaceuticals Inc. | 2023-08-25 |
| 00406-5111-01 | 100 CAPSULE in 1 BOTTLE (0406-5111-01) | Lisdexamfetamine Dimesylate | SpecGx LLC | 2023-08-25 |
| 00406-5112-01 | 100 CAPSULE in 1 BOTTLE (0406-5112-01) | Lisdexamfetamine Dimesylate | SpecGx LLC | 2023-08-25 |
| 00406-5113-01 | 100 CAPSULE in 1 BOTTLE (0406-5113-01) | Lisdexamfetamine Dimesylate | SpecGx LLC | 2023-08-25 |
| 00406-5114-01 | 100 CAPSULE in 1 BOTTLE (0406-5114-01) | Lisdexamfetamine Dimesylate | SpecGx LLC | 2023-08-25 |
| 00406-5115-01 | 100 CAPSULE in 1 BOTTLE (0406-5115-01) | Lisdexamfetamine Dimesylate | SpecGx LLC | 2023-08-25 |
| 00406-5116-01 | 100 CAPSULE in 1 BOTTLE (0406-5116-01) | Lisdexamfetamine Dimesylate | SpecGx LLC | 2023-08-25 |
| 00406-5117-01 | 100 CAPSULE in 1 BOTTLE (0406-5117-01) | Lisdexamfetamine Dimesylate | SpecGx LLC | 2023-08-25 |
| 00480-3564-01 | 100 CAPSULE in 1 BOTTLE (0480-3564-01) | Lisdexamfetamine dimesylate | Teva Pharmaceuticals, Inc. | 2024-12-17 |
| 00480-3565-01 | 100 CAPSULE in 1 BOTTLE (0480-3565-01) | Lisdexamfetamine dimesylate | Teva Pharmaceuticals, Inc. | 2024-12-17 |
| 00480-3566-01 | 100 CAPSULE in 1 BOTTLE (0480-3566-01) | Lisdexamfetamine dimesylate | Teva Pharmaceuticals, Inc. | 2024-12-17 |
| 00480-3567-01 | 100 CAPSULE in 1 BOTTLE (0480-3567-01) | Lisdexamfetamine dimesylate | Teva Pharmaceuticals, Inc. | 2024-12-17 |
| 00480-3568-01 | 100 CAPSULE in 1 BOTTLE (0480-3568-01) | Lisdexamfetamine dimesylate | Teva Pharmaceuticals, Inc. | 2024-12-17 |
| 00480-3569-01 | 100 CAPSULE in 1 BOTTLE (0480-3569-01) | Lisdexamfetamine dimesylate | Teva Pharmaceuticals, Inc. | 2024-12-17 |
| 00480-3570-01 | 100 CAPSULE in 1 BOTTLE (0480-3570-01) | Lisdexamfetamine dimesylate | Teva Pharmaceuticals, Inc. | 2024-12-17 |
| 00527-4661-37 | 100 CAPSULE in 1 BOTTLE (0527-4661-37) | Lisdexamfetamine Dimesylate | Lannett Company, Inc. | 2023-08-25 |
| 00527-4662-37 | 100 CAPSULE in 1 BOTTLE (0527-4662-37) | Lisdexamfetamine Dimesylate | Lannett Company, Inc. | 2023-08-25 |
| 00527-4663-37 | 100 CAPSULE in 1 BOTTLE (0527-4663-37) | Lisdexamfetamine Dimesylate | Lannett Company, Inc. | 2023-08-25 |
| 00527-4664-37 | 100 CAPSULE in 1 BOTTLE (0527-4664-37) | Lisdexamfetamine Dimesylate | Lannett Company, Inc. | 2023-08-25 |
| 00527-4665-37 | 100 CAPSULE in 1 BOTTLE (0527-4665-37) | Lisdexamfetamine Dimesylate | Lannett Company, Inc. | 2023-08-25 |
| 00527-4666-37 | 100 CAPSULE in 1 BOTTLE (0527-4666-37) | Lisdexamfetamine Dimesylate | Lannett Company, Inc. | 2023-08-25 |
| 00527-4667-37 | 100 CAPSULE in 1 BOTTLE (0527-4667-37) | Lisdexamfetamine Dimesylate | Lannett Company, Inc. | 2023-08-25 |
| 00781-2299-01 | 100 CAPSULE in 1 BOTTLE (0781-2299-01) | Lisdexamfetamine dimesylate | Sandoz Inc | 2025-09-16 |
| 00781-2476-01 | 100 CAPSULE in 1 BOTTLE (0781-2476-01) | Lisdexamfetamine dimesylate | Sandoz Inc | 2025-09-16 |
| 00781-2477-01 | 100 CAPSULE in 1 BOTTLE (0781-2477-01) | Lisdexamfetamine dimesylate | Sandoz Inc | 2025-09-16 |
| 00781-2478-01 | 100 CAPSULE in 1 BOTTLE (0781-2478-01) | Lisdexamfetamine dimesylate | Sandoz Inc | 2025-09-16 |
| 00781-2479-01 | 100 CAPSULE in 1 BOTTLE (0781-2479-01) | Lisdexamfetamine dimesylate | Sandoz Inc | 2025-09-16 |
| 00781-2480-01 | 100 CAPSULE in 1 BOTTLE (0781-2480-01) | Lisdexamfetamine dimesylate | Sandoz Inc | 2025-09-16 |
| 00781-2481-01 | 100 CAPSULE in 1 BOTTLE (0781-2481-01) | Lisdexamfetamine dimesylate | Sandoz Inc | 2025-09-16 |
| 31722-0350-01 | 100 CAPSULE in 1 BOTTLE (31722-350-01) | LISDEXAMFETAMINE DIMESYLATE | Camber Pharmaceuticals, Inc. | 2024-09-09 |
| 31722-0351-01 | 100 CAPSULE in 1 BOTTLE (31722-351-01) | LISDEXAMFETAMINE DIMESYLATE | Camber Pharmaceuticals, Inc. | 2024-09-09 |
| 31722-0352-01 | 100 CAPSULE in 1 BOTTLE (31722-352-01) | LISDEXAMFETAMINE DIMESYLATE | Camber Pharmaceuticals, Inc. | 2024-09-09 |
| 31722-0353-01 | 100 CAPSULE in 1 BOTTLE (31722-353-01) | LISDEXAMFETAMINE DIMESYLATE | Camber Pharmaceuticals, Inc. | 2024-09-09 |
| 31722-0354-01 | 100 CAPSULE in 1 BOTTLE (31722-354-01) | LISDEXAMFETAMINE DIMESYLATE | Camber Pharmaceuticals, Inc. | 2024-09-09 |
| 31722-0355-01 | 100 CAPSULE in 1 BOTTLE (31722-355-01) | LISDEXAMFETAMINE DIMESYLATE | Camber Pharmaceuticals, Inc. | 2024-09-09 |
| 31722-0356-01 | 100 CAPSULE in 1 BOTTLE (31722-356-01) | LISDEXAMFETAMINE DIMESYLATE | Camber Pharmaceuticals, Inc. | 2024-09-09 |
| 42291-0036-90 | 90 CAPSULE in 1 BOTTLE (42291-036-90) | Lisdexamfetamine Dimesylate | AvKARE | 2025-06-04 |
Observed labelers:
Sun Pharmaceutical Industries, Inc. (13) ·
Takeda Pharmaceuticals America, Inc. (13) ·
Alvogen Inc. (7) ·
Apotex Corp. (7) ·
Camber Pharmaceuticals, Inc. (7) ·
Elite Laboratories, Inc. (7)
· +13 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.